Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
Antonia Davidson
◽
Darin Brimhall
◽
Jonathan Kay
◽
Edward Keystone
◽
Sang Joon Lee
◽
...
2015 ◽
Vol 29
(6)
◽
pp. 381-388
◽
Donghoon Shin
◽
Youngdoe Kim
◽
Yoo Seok Kim
◽
Thomas Körnicke
◽
Rainard Fuhr
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 1005.2-1006
◽
D. Shin
◽
Y. Lee
◽
J.W. Kang
◽
R. Ellis-Pegler
Donna S. Cox
◽
Daniel F. Alvarez
◽
Amy E. Bock
◽
Carol L. Cronenberger
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 459.3-460
◽
D. Shin
◽
Y. Kim
◽
H.S. Kim
◽
R. Fuhr
◽
T. Körnicke
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 703.1-703
◽
D. Shin
◽
Y. Kim
◽
Y.S. Kim
◽
R. Fuhr
◽
T. Körnicke
2001 ◽
Vol 37
◽
pp. S294-S295
G. Masi
◽
A. Di Paolo
◽
G. Allegrini
◽
S. Cupini
◽
C. Galli
◽
...
1993 ◽
Vol 29
(7)
◽
pp. 983-988
◽
M. de Forni
◽
J.-P. Armand
◽
X. Fontana
◽
G. Recondo
◽
C. Domenge
◽
...
2011 ◽
Vol 69
(3)
◽
pp. 825-834
◽
Jordi Rodon
◽
Charlotte D. Jacobs
◽
Quincy Chu
◽
Eric K. Rowinsky
◽
Arturo Lopez-Anaya
◽
...